Blood Res.  2017 Dec;52(4):321-324. 10.5045/br.2017.52.4.321.

Post-liver transplant myeloid maturation arrest

• Patil A
• Bihari C
• Nigam N
• Deepika D
• Rastogi A
• Pamecha V

• KMID: 2405072
• DOI: http://doi.org/10.5045/br.2017.52.4.321

Abstract

No abstract available.

MeSH Terms

Liver Transplantation
Liver Cirrhosis
Cytomegalovirus Infections
Cytomegalovirus
Cirrhosis, Cryptogenic
Graft Rejection
Bone Marrow
Time Factors
Humans
Male
Middle Aged

Figure

• 

  Fig. 1 Bone marrow aspirate (A, May-Grunwald Giemsa stain, ×400) and biopsy (B, Haematoxylin-eosin stain, ×400) of patient 1 showing myeloid maturation arrest.

• 

  Fig. 2 Bone marrow aspirate (A, May-Grunwald Giemsa stain, ×400) and biopsy (B, Haematoxylin-eosin stain, ×400) of patient 2 showing myeloid maturation arrest. A colonic biopsy showed cytomegalovirus (CMV) inlusion bodies (C, Haematoxylin-eosin stain, ×400) and CMV immunohistochemical positivity (D, ×400).

Reference

1. De Bruyne RM, Dhawan A. Bone marrow dysfunction following pediatric liver transplantation. Pediatr Transplant. 2005; 9:423–426. PMID: 16048591.

2. Kuan FC, Lin PY, Hwang CE, Lu CH, Chen CC. Pancytopenia and myeloid maturation arrest in an autologous stem cell transplant recipient. Bone Marrow Transplant. 2011; 46:610–611. PMID: 20622905.

3. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966; 64:328–340. PMID: 5216294.

4. Knoll GA, MacDonald I, Khan A, Van Walraven C. Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol. 2003; 14:2381–2386. PMID: 12937317.

5. Rerolle JP, Szelag JC, Le Meur Y. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients. Nephrol Dial Transplant. 2006; 22:671–672. PMID: 16980323.

6. Jaffe E, Arber DA, Campo E, Harris NL, Quintanilla-Fend L. Hematopathology. 2nd ed. St. Louis, MO: Elsevier;2016.

7. Dhote R, Simon J, Papo T, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003; 49:633–639. PMID: 14558048.

8. Pal R, Monaghan SA, Hassett AC, et al. Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia. Blood. 2010; 115:605–614. PMID: 19965623.

9. Zacharias N, Gallichio MH, Conti DJ. Graft-versus-host disease after living-unrelated kidney transplantation. Case Rep Transplant. 2014; 2014:971426. PMID: 24812587.

10. Venton G, Crocchiolo R, Fürst S, et al. Risk factors of Ganciclovirrelated neutropenia after allogeneic stem cell transplantation: a retrospective monocentre study on 547 patients. Clin Microbiol Infect. 2014; 20:160–166. PMID: 23607363.

11. Page AV, Liles WC. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients. Curr Opin Organ Transplant. 2008; 13:575–580. PMID: 19060545.

12. Shoup M, Weisenberger JM, Wang JL, Pyle JM, Gamelli RL, Shankar R. Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann Surg. 1998; 228:112–122. PMID: 9671075.

13. Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007; 48:124–131. PMID: 16937360.